Immuron IMRN
NASDAQ IMRN
$0.97 -0.05 (-4.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Immuron (IMRN) Gross Profit (2023 - 2024)

Updated

Immuron (IMRN) posted Gross Profit of $4.98 million for FY2026 (year ended Aug 28, 2026).

Analysis

Immuron (IMRN) Gross Profit (2023 - 2024) Analysis & Trends

Since FY2015, Immuron has reported Gross Profit for 12 fiscal years.

  • Annual Gross Profit shows a five-year compound annual growth rate of 135.1% (FY2021 to FY2026).
  • The FY2026 figure stands as the highest annual Gross Profit in data going back to FY2015.
  • Business Quant data shows IMRN's Gross Profit at $4.77 million in FY2025, $33,368 in FY2024 (-97.9%), $1.58 million in FY2023 (+269.3%) and $427,920 in FY2022 (+517.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Immuron 7.32 Mn -9.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 2.18 Mn
Sep 9, 2024 22,234.25
Dec 31, 2023 8,522.42
API Access

Immuron Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=IMRN&period=max&api_key=YOUR_API_KEY